Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Fait

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Drugs in Context|January 15, 2019
Menopause hormone therapy: latest developments and clinical practiceTomas Fait
Neuro Endocrinology Letters|December 30, 2009
Can increased use of ART retrieve the Czech Republic from the low fertility trap?Jirina Kocourkova, Tomas Fait
Neuro Endocrinology Letters|November 28, 2012
Coronary heart disease and hormone replacement therapy - from primary and secondary prevention to the window of opportunityTomas Fait, Michal Vrablik
Bratislavske Lekarske Listy|January 14, 2024
The low birth weights of newborns conceived using assisted reproduction technologyEva Waldaufova, Anna Stastna, Tomas Fait
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 6, 2023
The association between preterm births and assisted reproductive technologiesAnna Stastna, Eva Waldaufova, Tomas Fait
Neuro Endocrinology Letters|April 3, 2012
Is screening for hereditary thrombophilia indicated in first early pregnancy loss?Dita Kasparova, Michal Vrablik, Tomas Fait
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 12, 2019
Prospective observational study to evaluate the efficacy and safety of the pollen extract Sérélys<sup>®</sup> in the management of women with menopausal symptomsTomas Fait, Manuela Sailer, Pedro-Antonio Regidor
Gynecologic and Obstetric Investigation|August 24, 2007
Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed studyTomas Fait, Michal Vrablik, Zdenek Zizka, et al.
Medicina (Kaunas, Lithuania)|June 27, 2024
Feasible Influence of G-CSF on Clinical Pregnancy Outcome in Oocyte Donation Cycles for Patients with Recurrent Implantation FailureNataliya Kushniruk, Anna Stastna, Tomas Fait, et al.
Metabolism: Clinical and Experimental|July 22, 2008
Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteinsMichal Vrablik, Tomas Fait, Jan Kovar, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Drugs in Context|January 15, 2019
Menopause hormone therapy: latest developments and clinical practiceTomas Fait
Neuro Endocrinology Letters|December 30, 2009
Can increased use of ART retrieve the Czech Republic from the low fertility trap?Jirina Kocourkova, Tomas Fait
Neuro Endocrinology Letters|November 28, 2012
Coronary heart disease and hormone replacement therapy - from primary and secondary prevention to the window of opportunityTomas Fait, Michal Vrablik
Bratislavske Lekarske Listy|January 14, 2024
The low birth weights of newborns conceived using assisted reproduction technologyEva Waldaufova, Anna Stastna, Tomas Fait
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 6, 2023
The association between preterm births and assisted reproductive technologiesAnna Stastna, Eva Waldaufova, Tomas Fait
Neuro Endocrinology Letters|April 3, 2012
Is screening for hereditary thrombophilia indicated in first early pregnancy loss?Dita Kasparova, Michal Vrablik, Tomas Fait
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 12, 2019
Prospective observational study to evaluate the efficacy and safety of the pollen extract Sérélys<sup>®</sup> in the management of women with menopausal symptomsTomas Fait, Manuela Sailer, Pedro-Antonio Regidor
Gynecologic and Obstetric Investigation|August 24, 2007
Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed studyTomas Fait, Michal Vrablik, Zdenek Zizka, et al.
Medicina (Kaunas, Lithuania)|June 27, 2024
Feasible Influence of G-CSF on Clinical Pregnancy Outcome in Oocyte Donation Cycles for Patients with Recurrent Implantation FailureNataliya Kushniruk, Anna Stastna, Tomas Fait, et al.
Metabolism: Clinical and Experimental|July 22, 2008
Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteinsMichal Vrablik, Tomas Fait, Jan Kovar, et al.
Pageof 3